Time Frame |
From date of first dose to date of last dose plus 30 days (up to approximately 17 months)
|
Adverse Event Reporting Description |
An adverse event was defined as any untoward or unfavorable medical occurrence in a human subject, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease temporally associated with the participant's participation in the research, whether or not considered related to the subject's participation in the research.
The Safety Population comprised all participants who received at least 1 partial dose of tarextumab or placebo.
|
|
Arm/Group Title
|
P1B: OMP-59R5 2.5 mg/kg + Gem
|
P1B: OMP-59R5 5 mg/kg + Gem
|
P1B: OMP-59R5 5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 7.5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 10 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 12.5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 15 mg/kg + Nab-P + Gem
|
P2: Placebo + Nab-P + Gem
|
P2: OMP-59R5 15 mg/kg + Nab-P + Gem
|
Arm/Group Description |
Cohort 1: Subjects receive OMP-59R5...
|
Cohort 2: Subjects receive OMP-59R5...
|
Cohort 3: Subjects receive OMP-59R5...
|
Cohort 4: Subjects receive OMP-59R5...
|
Cohort 5: Subjects receive OMP-59R5...
|
Cohort 6: Subjects receive OMP-59R5...
|
Expansion Cohort: Subjects receive ...
|
Placebo Arm: Subjects receive place...
|
Active Arm: Subjects receive OMP-59...
|
Arm/Group Description |
Cohort 1: Subjects receive OMP-59R5 2.5 mg/kg (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
Cohort 2: Subjects receive OMP-59R5 5 mg/kg (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
Cohort 3: Subjects receive OMP-59R5 5 mg/kg (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 125 mg/m2 Nab-Paclitaxel (Day 1, Day 8, and Day 15 of every 28-day treatment cycle) and 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
Cohort 4: Subjects receive OMP-59R5 7.5 mg/kg (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 125 mg/m2 Nab-Paclitaxel (Day 1, Day 8, and Day 15 of every 28-day treatment cycle) and 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
Cohort 5: Subjects receive OMP-59R5 10 mg/kg (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 125 mg/m2 Nab-Paclitaxel (Day 1, Day 8, and Day 15 of every 28-day treatment cycle) and 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
Cohort 6: Subjects receive OMP-59R5 12.5 mg/kg (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 125 mg/m2 Nab-Paclitaxel (Day 1, Day 8, and Day 15 of every 28-day treatment cycle) and 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
Expansion Cohort: Subjects receive OMP-59R5 15 mg/kg (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 125 mg/m2 Nab-Paclitaxel (Day 1, Day 8, and Day 15 of every 28-day treatment cycle) and 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
Placebo Arm: Subjects receive placebo (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 125 mg/m2 Nab-Paclitaxel (Day 1, Day 8, and Day 15 of every 28-day treatment cycle) and 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
Active Arm: Subjects receive OMP-59R5 15 mg/kg (administered on Day 1 and Day 15 of each 28-day treatment cycle) along with 125 mg/m2 Nab-Paclitaxel (Day 1, Day 8, and Day 15 of every 28-day treatment cycle) and 1000 mg/mg2 of Gemcitabine (Day 1, Day 8, and Day 15 of every 28-day treatment cycle).
|
|
|
P1B: OMP-59R5 2.5 mg/kg + Gem
|
P1B: OMP-59R5 5 mg/kg + Gem
|
P1B: OMP-59R5 5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 7.5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 10 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 12.5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 15 mg/kg + Nab-P + Gem
|
P2: Placebo + Nab-P + Gem
|
P2: OMP-59R5 15 mg/kg + Nab-P + Gem
|
|
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Total |
3/5 (60.00%) |
4/4 (100.00%) |
4/4 (100.00%) |
5/6 (83.33%) |
6/6 (100.00%) |
3/3 (100.00%) |
10/12 (83.33%) |
60/88 (68.18%) |
71/89 (79.78%) |
|
|
P1B: OMP-59R5 2.5 mg/kg + Gem
|
P1B: OMP-59R5 5 mg/kg + Gem
|
P1B: OMP-59R5 5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 7.5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 10 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 12.5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 15 mg/kg + Nab-P + Gem
|
P2: Placebo + Nab-P + Gem
|
P2: OMP-59R5 15 mg/kg + Nab-P + Gem
|
|
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Total |
4/5 (80.00%) |
1/4 (25.00%) |
1/4 (25.00%) |
3/6 (50.00%) |
4/6 (66.67%) |
1/3 (33.33%) |
9/12 (75.00%) |
51/85 (60.00%) |
58/87 (66.67%) |
Blood and lymphatic system disorders |
|
|
|
|
|
|
|
|
|
Anaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
2/12 (16.67%) |
2/85 (2.35%) |
4/87 (4.60%) |
Thrombocytopenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
6/87 (6.90%) |
Febrile neutropenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
0/87 (0.00%) |
Neutropenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Haemolytic uraemic syndrome |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Leukopenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Microangiopathic haemolytic anaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pancytopenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Thrombotic thrombocytopenic purpura |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Cardiac disorders |
|
|
|
|
|
|
|
|
|
Atrial fibrillation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
0/87 (0.00%) |
Cardiac arrest |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Cardiac failure congestive |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Cardio-respiratory arrest |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Cardiomyopathy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Myocardial infarction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Sinus bradycardia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Gastrointestinal disorders |
|
|
|
|
|
|
|
|
|
Gastrointestinal haemorrhage |
1/5 (20.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
3/12 (25.00%) |
4/85 (4.71%) |
6/87 (6.90%) |
Constipation |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
2/87 (2.30%) |
Diarrhoea |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
2/85 (2.35%) |
7/87 (8.05%) |
Duodenal obstruction |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Duodenal ulcer |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Faecaloma |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Gastric ulcer haemorrhage |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Nausea |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
1/85 (1.18%) |
4/87 (4.60%) |
Small intestinal obstruction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
4/85 (4.71%) |
2/87 (2.30%) |
Upper gastrointestinal haemorrhage |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Vomiting |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
3/85 (3.53%) |
5/87 (5.75%) |
Small intestinal perforation |
0/5 (0.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Abdominal pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
1/87 (1.15%) |
Obstruction gastric |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
2/87 (2.30%) |
Ileus |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Ascites |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Haematochezia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Impaired gastric emptying |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Intestinal perforation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Large intestine perforation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
General disorders |
|
|
|
|
|
|
|
|
|
Fatigue |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
1/87 (1.15%) |
Death |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pyrexia |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
9/85 (10.59%) |
5/87 (5.75%) |
Asthenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Catheter site haemorrhage |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Catheter site pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Oedema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Oedema peripheral |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Systemic inflammatory response syndrome |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hepatobiliary disorders |
|
|
|
|
|
|
|
|
|
Cholangitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
3/87 (3.45%) |
Hyperbilirubinaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
2/87 (2.30%) |
Bile duct stenosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Cholangitis acute |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Cholecystitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hepatic failure |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Immune system disorders |
|
|
|
|
|
|
|
|
|
Hypersensitivity |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Infections and infestations |
|
|
|
|
|
|
|
|
|
Pneumonia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
1/12 (8.33%) |
4/85 (4.71%) |
3/87 (3.45%) |
Cellulitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
6/85 (7.06%) |
0/87 (0.00%) |
Biliary tract infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Escherichia bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
1/87 (1.15%) |
Enterobacter bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Escherichia sepsis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Cholecystitis infective |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Urinary tract infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
2/87 (2.30%) |
Atypical pneumonia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Clostridium difficile colitis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Clostridium difficile infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Gastroenteritis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Groin Abscess |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Herpes zoster |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Gastroenteritis viral |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Klebsiella bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Lobar pneumonia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Peritonitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Peritonitis bacterial |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Staphylococcal bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Staphylococcal sepsis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Sepsis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
6/85 (7.06%) |
4/87 (4.60%) |
Staphylococcal skin infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Subcutaneous abscess |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Injury, poisoning and procedural complications |
|
|
|
|
|
|
|
|
|
Subdural haematoma |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Infusion related reaction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Lumbar vertebral fracture |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Investigations |
|
|
|
|
|
|
|
|
|
Blood bilirubin increased |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Alanine aminotransferase increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Lipase increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Metabolism and nutrition disorders |
|
|
|
|
|
|
|
|
|
Hypoglycaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Dehydration |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
5/85 (5.88%) |
3/87 (3.45%) |
Failure to thrive |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Hypercalcaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hypokalaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hyponatraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Musculoskeletal and connective tissue disorders |
|
|
|
|
|
|
|
|
|
Arthralgia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Back pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Flank pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Neoplasms benign, malignant and unspecified (incl cysts and polyps) |
|
|
|
|
|
|
|
|
|
Metastases to liver |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Pancreatic carcinoma |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
8/87 (9.20%) |
Pancreatic carcinoma metastatic |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Nervous system disorders |
|
|
|
|
|
|
|
|
|
Metabolic encephalopathy |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Presyncope |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Thrombotic stroke |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Cerebrovascular accident |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Cerebral infarction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Encephalopathy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Ischaemic stroke |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Renal and urinary disorders |
|
|
|
|
|
|
|
|
|
Renal failure acute |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
3/87 (3.45%) |
Nephrolithiasis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Respiratory, thoracic and mediastinal disorders |
|
|
|
|
|
|
|
|
|
Pulmonary embolism |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
5/87 (5.75%) |
Pleural effusion |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Pulmonary infarction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Respiratory failure |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
2/87 (2.30%) |
Dyspnoea |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Epistaxis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Pneumonitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Acute pulmonary oedema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Hypoxia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Lung infiltration |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Pulmonary toxicity |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Skin and subcutaneous tissue disorders |
|
|
|
|
|
|
|
|
|
Skin ulcer |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Drug eruption |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Rash maculo-papular |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Vascular disorders |
|
|
|
|
|
|
|
|
|
Venous thrombosis limb |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Deep vein thrombosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Embolism |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Hypotension |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Arterial occlusive disease |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Haematoma |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hypertension |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Term from vocabulary, MedDRA version 15.1
Indicates events were collected by non-systematic assessment
|
|
Frequency Threshold for Reporting Other Adverse Events
|
0%
|
|
P1B: OMP-59R5 2.5 mg/kg + Gem
|
P1B: OMP-59R5 5 mg/kg + Gem
|
P1B: OMP-59R5 5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 7.5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 10 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 12.5 mg/kg + Nab-P + Gem
|
P1B: OMP-59R5 15 mg/kg + Nab-P + Gem
|
P2: Placebo + Nab-P + Gem
|
P2: OMP-59R5 15 mg/kg + Nab-P + Gem
|
|
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Affected / at Risk (%) |
Total |
5/5 (100.00%) |
4/4 (100.00%) |
4/4 (100.00%) |
6/6 (100.00%) |
6/6 (100.00%) |
3/3 (100.00%) |
12/12 (100.00%) |
85/85 (100.00%) |
87/87 (100.00%) |
Blood and lymphatic system disorders |
|
|
|
|
|
|
|
|
|
Thrombocytopenia |
3/5 (60.00%) |
2/4 (50.00%) |
4/4 (100.00%) |
5/6 (83.33%) |
5/6 (83.33%) |
2/3 (66.67%) |
7/12 (58.33%) |
38/85 (44.71%) |
62/87 (71.26%) |
Anemia |
4/5 (80.00%) |
2/4 (50.00%) |
2/4 (50.00%) |
3/6 (50.00%) |
5/6 (83.33%) |
2/3 (66.67%) |
9/12 (75.00%) |
46/85 (54.12%) |
50/87 (57.47%) |
Neutropenia |
2/5 (40.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
3/6 (50.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
42/85 (49.41%) |
21/87 (24.14%) |
Lymphopenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Leukopenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
12/85 (14.12%) |
11/87 (12.64%) |
Pancytopenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Febrile neutropenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
0/87 (0.00%) |
Coagulopathy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Haemolytic uraemic syndrome |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Hypercoagulation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Leukocytosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Lymph node pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Microangiopathic haemolytic anaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Normochromic normocytic anaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Splenic infarction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Splenic vein thrombosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Thrombocytosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Cardiac disorders |
|
|
|
|
|
|
|
|
|
Atrial fibrillation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
1/87 (1.15%) |
Intracardiac thrombus |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Palpitations |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Sinus tachycardia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Tachycardia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
4/85 (4.71%) |
6/87 (6.90%) |
Cardiac arrest |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Cardiac failure congestive |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Myocardial infarction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Bradycardia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Bundle branch block left |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Cardio-respiratory arrest |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Cardiomyopathy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Left ventricular dysfunction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Mitral valve incompetence |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pericardial effusion |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Sinus bradycardia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Ventricular tachycardia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Ear and labyrinth disorders |
|
|
|
|
|
|
|
|
|
Tinnitus |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Ear pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Middle ear inflammation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Vertigo |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Eye disorders |
|
|
|
|
|
|
|
|
|
Eye pruritus |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Vision blurred |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
5/85 (5.88%) |
0/87 (0.00%) |
Dry eye |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
2/87 (2.30%) |
Ocular icterus |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Cataract |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Eye irritation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Eye pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Ocular hyperaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Visual impairment |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Xanthopsia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Gastrointestinal disorders |
|
|
|
|
|
|
|
|
|
Nausea |
0/5 (0.00%) |
0/4 (0.00%) |
2/4 (50.00%) |
2/6 (33.33%) |
3/6 (50.00%) |
1/3 (33.33%) |
9/12 (75.00%) |
47/85 (55.29%) |
55/87 (63.22%) |
Vomiting |
0/5 (0.00%) |
0/4 (0.00%) |
2/4 (50.00%) |
2/6 (33.33%) |
3/6 (50.00%) |
1/3 (33.33%) |
8/12 (66.67%) |
32/85 (37.65%) |
33/87 (37.93%) |
Constipation |
2/5 (40.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
5/12 (41.67%) |
26/85 (30.59%) |
14/87 (16.09%) |
Abdominal pain |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
3/6 (50.00%) |
0/3 (0.00%) |
3/12 (25.00%) |
21/85 (24.71%) |
16/87 (18.39%) |
Abdominal pain upper |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
5/85 (5.88%) |
5/87 (5.75%) |
Dyspepsia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
6/85 (7.06%) |
4/87 (4.60%) |
Gastrooesphageal reflux disease |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
2/6 (33.33%) |
1/6 (16.67%) |
0/3 (0.00%) |
3/12 (25.00%) |
2/85 (2.35%) |
2/87 (2.30%) |
Gastrointestinal Haemorrhage |
1/5 (20.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
3/12 (25.00%) |
4/85 (4.71%) |
7/87 (8.05%) |
Abdominal distension |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
0/3 (0.00%) |
0/12 (0.00%) |
9/85 (10.59%) |
8/87 (9.20%) |
Flatulence |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
2/6 (33.33%) |
0/3 (0.00%) |
11/12 (91.67%) |
3/85 (3.53%) |
2/87 (2.30%) |
Abdominal discomfort |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
2/87 (2.30%) |
Anorectal discomfort |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Ascites |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
7/85 (8.24%) |
1/87 (1.15%) |
Haemorrhoids |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
2/87 (2.30%) |
Colitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Dental Caries |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Duodenal obstruction |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Duodenal ulcer |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Dysphagia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Eructation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Faecaloma |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Gastric ulcer haemorrhage |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Gastrointestinal disorder |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Melaena |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
1/87 (1.15%) |
Oesophageal ulcer |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Oral disorder |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Oral pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Pancreatic insufficiency |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Rectal fissure |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Rectal haemorrhage |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
1/87 (1.15%) |
Small intestinal obstruction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
4/85 (4.71%) |
2/87 (2.30%) |
Small intestinal perforation |
0/5 (0.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Stomatitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
4/85 (4.71%) |
5/87 (5.75%) |
Upper gastrointestinal haemorrhage |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Dry mouth |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
4/87 (4.60%) |
Haematochezia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
2/87 (2.30%) |
Obstruction gastric |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
2/87 (2.30%) |
Ileus |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Impaired gastric emptying |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Inguinal hernia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Retching |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Abdominal pain lower |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Abdominal rigidity |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Abdominal tenderness |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Change of bowel habit |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Cheilitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Diarrhoea haemorrhagic |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Duodenal stenosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Epigastric discomfort |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Faeces soft |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Gastric ulcer |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Gastritis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Haematemesis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Intestinal perforation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Large intestine perforation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Lip swelling |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Oesophagitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pneumoperitoneum |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Sensitivity of teeth |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Tongue discolouration |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Tongue disorder |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Tooth disorder |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Systemic inflammatory response syndrome |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
General disorders |
|
|
|
|
|
|
|
|
|
Diarrhoea |
3/5 (60.00%) |
1/4 (25.00%) |
4/4 (100.00%) |
4/6 (66.67%) |
4/6 (66.67%) |
1/3 (33.33%) |
10/12 (83.33%) |
41/85 (48.24%) |
71/87 (81.61%) |
Fatigue |
2/5 (40.00%) |
0/4 (0.00%) |
2/4 (50.00%) |
4/6 (66.67%) |
5/6 (83.33%) |
0/3 (0.00%) |
11/12 (91.67%) |
59/85 (69.41%) |
63/87 (72.41%) |
Oedema Peripheral |
2/5 (40.00%) |
0/4 (0.00%) |
4/4 (100.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
0/3 (0.00%) |
3/12 (25.00%) |
27/85 (31.76%) |
14/87 (16.09%) |
Pyrexia |
2/5 (40.00%) |
0/4 (0.00%) |
3/4 (75.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
5/12 (41.67%) |
36/85 (42.35%) |
22/87 (25.29%) |
Asthenia |
0/5 (0.00%) |
0/4 (0.00%) |
2/4 (50.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
4/12 (33.33%) |
10/85 (11.76%) |
9/87 (10.34%) |
Chills |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
3/12 (25.00%) |
13/85 (15.29%) |
7/87 (8.05%) |
Mucosal inflammation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
2/12 (16.67%) |
4/85 (4.71%) |
6/87 (6.90%) |
Early satiety |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Gait disturbance |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
2/85 (2.35%) |
2/87 (2.30%) |
Influenza like illness |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
2/87 (2.30%) |
Catheter site erythema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Catheter site pruritus |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Chest Pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
1/87 (1.15%) |
Face oedema |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Instillation site erythema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Localised oedema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
3/85 (3.53%) |
0/87 (0.00%) |
Medical device complication |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
14/85 (16.47%) |
17/87 (19.54%) |
Oedema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
12/85 (14.12%) |
6/87 (6.90%) |
Malaise |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
5/85 (5.88%) |
1/87 (1.15%) |
Infusion site pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
3/87 (3.45%) |
Chest discomfort |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
2/87 (2.30%) |
Infusion site discomfort |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Peripheral swelling |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Catheter site haemorrhage |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Catheter site pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Device occlusion |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Infusion site irritation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Injection site reaction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Non-cardiac chest pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Hepatobiliary disorders |
|
|
|
|
|
|
|
|
|
Cholangitis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
3/87 (3.45%) |
Hyperbilirubinaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
2/87 (2.30%) |
Jaundice |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Bile duct obstruction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
5/85 (5.88%) |
3/87 (3.45%) |
Portal vein thrombosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Bile duct stenosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Cholangitis acute |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Cholangitis sclerosing |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Cholecystitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Gallbladder perforation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Hepatic failure |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Hepatic pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Immune system disorders |
|
|
|
|
|
|
|
|
|
Seasonal allergy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hypersensitivity |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Infections and infestations |
|
|
|
|
|
|
|
|
|
Pneumonia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
3/12 (25.00%) |
6/85 (7.06%) |
5/87 (5.75%) |
Upper respiratory tract infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
3/12 (25.00%) |
7/85 (8.24%) |
2/87 (2.30%) |
Oral candidiasis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
0/87 (0.00%) |
Staphylococcal infection |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Urinary tract infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
4/85 (4.71%) |
10/87 (11.49%) |
Bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Bronchitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Candidiasis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Cellulitis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
11/85 (12.94%) |
3/87 (3.45%) |
Clostridium difficile colitis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Folliculitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
3/87 (3.45%) |
Gastroenteritis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Gastroenteritis viral |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Hordeolum |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
0/87 (0.00%) |
Infected dermal cyst |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
0/87 (0.00%) |
Liver abscess |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Mucosal infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Rhinitis |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Sepsis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
6/85 (7.06%) |
4/87 (4.60%) |
Sinusitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Soft tissue infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Staphylococcal skin infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Subcutaneous abscess |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Escherichia bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
1/87 (1.15%) |
Clostridium difficile infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
3/87 (3.45%) |
Cystitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
0/87 (0.00%) |
Fungal skin infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
0/87 (0.00%) |
Nasopharyngitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Candida infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Device related infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Furuncle |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Herpes zoster |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Pharyngitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Atypical pneumonia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Biliary tract infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Catheter site infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Cholecystitis infective |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Diverticulitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Enterobacter bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Escherichia sepsis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Groin abscess |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Klebsiella bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Lobar pneumonia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Localised infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Oral herpes |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Oral infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Otitis externa |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Paronychia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Parotitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Peritonitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Peritonitis bacterial |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pneumonia klebsiella |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Rash pustular |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Skin infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Staphylococcal bacteraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Staphylococcal sepsis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Tooth infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Wound infection |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Injury, poisoning and procedural complications |
|
|
|
|
|
|
|
|
|
Fall |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
2/87 (2.30%) |
Infusion related reaction |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
5/87 (5.75%) |
Laceration |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Ankle fracture |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Arthropod bite |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Contusion |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Limb injury |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Subdermal haematoma |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Wrist fracture |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Lumbar vertebral fracture |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Foot fracture |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Procedural pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Skeletal injury |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Spinal fracture |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Sunburn |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Wound dehiscence |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Investigations |
|
|
|
|
|
|
|
|
|
Weight decreased |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
3/6 (50.00%) |
2/6 (33.33%) |
0/3 (0.00%) |
3/12 (25.00%) |
9/85 (10.59%) |
12/87 (13.79%) |
White blood cell count decreased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
3/12 (25.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Blood alkaline phosphatase increased |
2/5 (40.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
14/85 (16.47%) |
13/87 (14.94%) |
Alanine aminotransferase increased |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
14/85 (16.47%) |
12/87 (13.79%) |
Aspartate aminotransferase increased |
2/5 (40.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
13/85 (15.29%) |
9/87 (10.34%) |
Blood bilirubin increased |
2/5 (40.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
6/85 (7.06%) |
8/87 (9.20%) |
International normalised ratio increased |
0/5 (0.00%) |
2/4 (50.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
5/85 (5.88%) |
3/87 (3.45%) |
Lymphocyte count decreased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
8/85 (9.41%) |
5/87 (5.75%) |
Activated partial thromboplastin time prolonged |
0/5 (0.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
2/87 (2.30%) |
Blood creatinine increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Cardiac murmur |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Prothrombin time prolonged |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Blood glucose increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Electrocardiogram QT prolonged |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Bilirubin conjugated increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Blood albumin decreased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Blood creatinine decreased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Blood fibrinogen decreased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Blood parathyroid hormone decreased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Blood phosphorus increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Computerised tomogram thorax abnormal |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Eosinophil count decreased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Haematocrit decreased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Lipase increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Liver function test abnormal |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Lymphocyte count increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Neutrophil count increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
White blood cell count increased |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Metabolism and nutrition disorders |
|
|
|
|
|
|
|
|
|
Decreased appetite |
1/5 (20.00%) |
0/4 (0.00%) |
2/4 (50.00%) |
2/6 (33.33%) |
2/6 (33.33%) |
1/3 (33.33%) |
8/12 (66.67%) |
22/85 (25.88%) |
27/87 (31.03%) |
Hypokalaemia |
1/5 (20.00%) |
1/4 (25.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
1/3 (33.33%) |
4/12 (33.33%) |
14/85 (16.47%) |
23/87 (26.44%) |
Dehydration |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
2/6 (33.33%) |
0/3 (0.00%) |
6/12 (50.00%) |
18/85 (21.18%) |
19/87 (21.84%) |
Hypoalbuminaemia |
1/5 (20.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
11/85 (12.94%) |
8/87 (9.20%) |
Hypocalcaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
4/12 (33.33%) |
9/85 (10.59%) |
11/87 (12.64%) |
Hyponatraemia |
0/5 (0.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
3/12 (25.00%) |
11/85 (12.94%) |
5/87 (5.75%) |
Hyperglycaemia |
0/5 (0.00%) |
1/4 (25.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
9/85 (10.59%) |
7/87 (8.05%) |
Hypophosphataemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
3/12 (25.00%) |
9/85 (10.59%) |
6/87 (6.90%) |
Hypercreatininaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
1/3 (33.33%) |
0/12 (0.00%) |
3/85 (3.53%) |
1/87 (1.15%) |
Hypoglycaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
0/87 (0.00%) |
Hypomagnesaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
9/85 (10.59%) |
5/87 (5.75%) |
Hyperkalaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
5/85 (5.88%) |
1/87 (1.15%) |
Hypercalcaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
1/87 (1.15%) |
Failure to thrive |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
2/87 (2.30%) |
Acidosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Fluid retention |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Hypernatraemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Iron deficiency |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Metabolic acidosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Musculoskeletal and connective tissue disorders |
|
|
|
|
|
|
|
|
|
Pain in extremity |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
1/3 (33.33%) |
2/12 (16.67%) |
4/85 (4.71%) |
4/87 (4.60%) |
Arthralgia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
3/12 (25.00%) |
13/85 (15.29%) |
8/87 (9.20%) |
Back pain |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
2/6 (33.33%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
10/85 (11.76%) |
8/87 (9.20%) |
Muscle spasms |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
4/85 (4.71%) |
0/87 (0.00%) |
Myalgia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
8/85 (9.41%) |
3/87 (3.45%) |
Arthritis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Exostosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Flank pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
2/87 (2.30%) |
Muscular weakness |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Musculoskeletal pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Osteopenia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Pain in jaw |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Pubic pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Hypercreatinaemia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
4/87 (4.60%) |
Limb discomfort |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Musculoskeletal discomfort |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Neck pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Musculoskeletal chest pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Bone pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Neoplasms benign, malignant and unspecified (incl cysts and polyps) |
|
|
|
|
|
|
|
|
|
Metastases to liver |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Pancreatic carcinoma |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
8/87 (9.20%) |
Malignant ascites |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pancreatic carcinoma metastatic |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Nervous system disorders |
|
|
|
|
|
|
|
|
|
Neuropathy Peripheral |
0/5 (0.00%) |
0/4 (0.00%) |
2/4 (50.00%) |
3/6 (50.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
4/12 (33.33%) |
19/85 (22.35%) |
17/87 (19.54%) |
Dizziness |
1/5 (20.00%) |
0/4 (0.00%) |
2/4 (50.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
0/3 (0.00%) |
0/12 (0.00%) |
18/85 (21.18%) |
11/87 (12.64%) |
Dysgeusia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
4/12 (33.33%) |
15/85 (17.65%) |
20/87 (22.99%) |
Peripheral sensory neuropathy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
0/3 (0.00%) |
2/12 (16.67%) |
15/85 (17.65%) |
7/87 (8.05%) |
Headache |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
9/85 (10.59%) |
8/87 (9.20%) |
Ageusia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Dysaesthesia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Hypoaesthesia |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
2/87 (2.30%) |
Metabolic encephalopathy |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Peripheral motor neuropathy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
3/85 (3.53%) |
1/87 (1.15%) |
Presyncope |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Syncope |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
3/87 (3.45%) |
Thrombotic stroke |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Tremor |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Paraesthesia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
6/87 (6.90%) |
Cerebrovascular accident |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Encephalopathy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Lethargy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Memory impairment |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Neuralgia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Somnolence |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Amnesia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Balance disorder |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Burning sensation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Cerebral infarction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hemianopia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hyporeflexia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Ischaemic stroke |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Migraine |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Motor dysfunction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Nystagmus |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Peroneal nerve palsy |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Restless legs syndrome |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Sciatica |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Sedation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Psychiatric disorders |
|
|
|
|
|
|
|
|
|
Depression |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
9/85 (10.59%) |
4/87 (4.60%) |
Anxiety |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
6/85 (7.06%) |
6/87 (6.90%) |
Insomnia |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
9/85 (10.59%) |
11/87 (12.64%) |
Confusional state |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Restlessness |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Agitation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Irritability |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Irritability |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Mental status changes |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Somnambulism |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Renal and urinary disorders |
|
|
|
|
|
|
|
|
|
Haematuria |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
1/87 (1.15%) |
Hypertonic bladder |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Urinary retention |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Renal failure acute |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
6/85 (7.06%) |
3/87 (3.45%) |
Urinary incontinence |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
2/87 (2.30%) |
Dysuria |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
3/87 (3.45%) |
Proteinuria |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Cystitis noninfective |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Glycosuria |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hydronephrosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Nephrolithiasis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Nocturia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Oliguria |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Renal failure |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Renal failure chronic |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Urinary tract pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Reproductive system and breast disorders |
|
|
|
|
|
|
|
|
|
Benign prostatic hyperplasia |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Priapism |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Scrotal cyst |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Breast pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Ovarian vein thrombosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Scrotal oedema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Vaginal discharge |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Vaginal haemorrhage |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Respiratory, thoracic and mediastinal disorders |
|
|
|
|
|
|
|
|
|
Epistaxis |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
0/3 (0.00%) |
3/12 (25.00%) |
8/85 (9.41%) |
18/87 (20.69%) |
Dyspnoea |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
2/12 (16.67%) |
22/85 (25.88%) |
16/87 (18.39%) |
Cough |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
1/12 (8.33%) |
11/85 (12.94%) |
13/87 (14.94%) |
Pulmonary embolism |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
0/3 (0.00%) |
0/12 (0.00%) |
8/85 (9.41%) |
7/87 (8.05%) |
Dysphonia |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
1/87 (1.15%) |
Hiccups |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
1/87 (1.15%) |
Pleural effusion |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
2/87 (2.30%) |
Productive cough |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
5/85 (5.88%) |
4/87 (4.60%) |
Respiratory tract congestion |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Acute respiratory failure |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Hypoxia |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Painful respiration |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Pulmonary infarction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Respiratory failure |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
2/87 (2.30%) |
Rhinitis allergic |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Rhinitis allergic |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Rhinorrhoea |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Upper-airway cough syndrome |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
2/87 (2.30%) |
Oropharyngeal pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
6/87 (6.90%) |
Pneumonitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
5/85 (5.88%) |
2/87 (2.30%) |
Dyspnoea exertional |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
1/87 (1.15%) |
Wheezing |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
2/87 (2.30%) |
Nasal congestion |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
1/87 (1.15%) |
Nasal discomfort |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Pleuritic pain |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Acute pulmonary oedema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Haemoptysis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Lung infiltration |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Nasal dryness |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Nasal ulcer |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Pulmonary oedema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pulmonary toxicity |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Rales |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Sinus disorder |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Tachypnoea |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Throat irritation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Skin and subcutaneous tissue disorders |
|
|
|
|
|
|
|
|
|
Alopecia |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
4/6 (66.67%) |
3/6 (50.00%) |
1/3 (33.33%) |
6/12 (50.00%) |
26/85 (30.59%) |
22/87 (25.29%) |
Pruritus |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
3/12 (25.00%) |
7/85 (8.24%) |
10/87 (11.49%) |
Erythema |
2/5 (40.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
1/12 (8.33%) |
3/85 (3.53%) |
1/87 (1.15%) |
Rash |
1/5 (20.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
2/6 (33.33%) |
0/3 (0.00%) |
1/12 (8.33%) |
19/85 (22.35%) |
18/87 (20.69%) |
Rash maculo-papular |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
2/6 (33.33%) |
0/3 (0.00%) |
2/12 (16.67%) |
1/85 (1.18%) |
6/87 (6.90%) |
Decubitus ulcer |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
2/12 (16.67%) |
1/85 (1.18%) |
0/87 (0.00%) |
Petechiae |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Rash macular |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Skin hyperpigmentation |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
0/87 (0.00%) |
Skin ulcer |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Blister |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Dermal cyst |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Dry skin |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
2/85 (2.35%) |
4/87 (4.60%) |
Ecchymosis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Ingrowing nail |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Pruritus generalized |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Rash pruritic |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Skin discoloration |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
1/6 (16.67%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
0/87 (0.00%) |
Skin exfoliation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
0/85 (0.00%) |
0/87 (0.00%) |
Rash |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
19/85 (22.35%) |
18/87 (20.69%) |
Dermatitis acneiform |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
2/87 (2.30%) |
Hyperhidrosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
5/85 (5.88%) |
0/87 (0.00%) |
Nail discolouration |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
3/85 (3.53%) |
0/87 (0.00%) |
Nail disorder |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
1/87 (1.15%) |
Night sweats |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Rash papular |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Acne |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Dermatitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Drug eruption |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Nail pigmentation |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Nail ridging |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Onychoclasis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Onychomadesis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Pain of skin |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Photosensitivity reaction |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Pruritus generalised |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Skin disorder |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Skin mass |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Skin abrasion |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Vascular disorders |
|
|
|
|
|
|
|
|
|
Hypotension |
1/5 (20.00%) |
0/4 (0.00%) |
2/4 (50.00%) |
0/6 (0.00%) |
2/6 (33.33%) |
0/3 (0.00%) |
4/12 (33.33%) |
6/85 (7.06%) |
10/87 (11.49%) |
Deep vein thrombosis |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
2/6 (33.33%) |
1/6 (16.67%) |
0/3 (0.00%) |
1/12 (8.33%) |
12/85 (14.12%) |
5/87 (5.75%) |
Hot flush |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
1/6 (16.67%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
1/85 (1.18%) |
0/87 (0.00%) |
Orthostatic hypotension |
0/5 (0.00%) |
1/4 (25.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Embolism |
0/5 (0.00%) |
0/4 (0.00%) |
1/4 (25.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
4/85 (4.71%) |
1/87 (1.15%) |
Hypertension |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
1/12 (8.33%) |
5/85 (5.88%) |
0/87 (0.00%) |
Venous thrombosis limb |
1/5 (20.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Flushing |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
2/87 (2.30%) |
Haematoma |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
2/87 (2.30%) |
Phlebitis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
2/85 (2.35%) |
0/87 (0.00%) |
Thrombosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
1/87 (1.15%) |
Arterial occlusive disease |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Arteriosclerosis |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Embolism venous |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Lymphoedema |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Orthostatic hypertension |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
0/85 (0.00%) |
1/87 (1.15%) |
Peripheral coldness |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Shock haemorrhagic |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Thrombophlebitis superficial |
0/5 (0.00%) |
0/4 (0.00%) |
0/4 (0.00%) |
0/6 (0.00%) |
0/6 (0.00%) |
0/3 (0.00%) |
0/12 (0.00%) |
1/85 (1.18%) |
0/87 (0.00%) |
Term from vocabulary, MedDRA version 15.1
Indicates events were collected by non-systematic assessment
"Gastrointestinal disorder" is a single adverse event system organ class/preferred term used under the Gastrointestinal disorders
|